Ionis Pharmaceuticals | IONS - Despesas De Vendas E Administração

Preço das Ações
73.27
Mudança Diária
-0.82 -1.11%
Mensal
0.78%
Anual
146.70%
Q2 Previsão
71.70




Despesas De Vendas E Administração Alterar Data
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Astellas Pharma JPY 221.78B 14.94B 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Esperion Therapeutics USD 39.42M 456K 2025-12
Exelixis USD 123.02M 19.9M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 308M 40M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.44B 128M 2025-12
Omeros USD 11.32M 2.48M 2024-09
OPKO Health USD 50.52M 3.28M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 4.08B 894M 2025-12
Pharma Mar EUR 17.31M 3.6M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tilray USD 24.85M 1.7M 2025-09
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09